massarray® colon panel (Sequenom)
90
Structured Review
Sequenom
massarray® colon panel
Massarray® Colon Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/massarray++colon+panel/pm29959022-101-76-79
Average 90 stars, based on 1 article reviews
Massarray® Colon Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/massarray++colon+panel/pm29959022-101-76-79
Average 90 stars, based on 1 article reviews
massarray® colon panel - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Mutagenesis:Article Title: Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer. Article Snippet: M AN US CR IP T AC CE PT ED 13 Routine NRAS and BRAF mutation tests used as reference method The following routine reference methods were used to determine both the mutational status of NRAS and BRAF: NGS using the Ion Torrent AmpliSeqTM Colon and Lung Cancer Research Panel v.2 (Thermo Fisher Scientific, Waltham, MA), the Oncomine Solid Tumor DNA kit (Thermo Fisher Scientific; Waltham, MA), or in-house developed NGS, mass spectrometry methods using the MassARRAY® Colon Panel (Sequenom, San Diego, CA) or the Myriapod® Colon kit (Diatech, Jesi, Italy), and Sanger sequencing using the ABI PRISM® SNaPshot® Multiplex Kit (Applied Biosystems, Foster City, CA) or in-house methods. Next-Generation Sequencing:Article Title: Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer. Article Snippet: M AN US CR IP T AC CE PT ED 13 Routine NRAS and BRAF mutation tests used as reference method The following routine reference methods were used to determine both the mutational status of NRAS and BRAF: NGS using the Ion Torrent AmpliSeqTM Colon and Lung Cancer Research Panel v.2 (Thermo Fisher Scientific, Waltham, MA), the Oncomine Solid Tumor DNA kit (Thermo Fisher Scientific; Waltham, MA), or in-house developed NGS, mass spectrometry methods using the MassARRAY® Colon Panel (Sequenom, San Diego, CA) or the Myriapod® Colon kit (Diatech, Jesi, Italy), and Sanger sequencing using the ABI PRISM® SNaPshot® Multiplex Kit (Applied Biosystems, Foster City, CA) or in-house methods. Mass Spectrometry:Article Title: Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer. Article Snippet: M AN US CR IP T AC CE PT ED 13 Routine NRAS and BRAF mutation tests used as reference method The following routine reference methods were used to determine both the mutational status of NRAS and BRAF: NGS using the Ion Torrent AmpliSeqTM Colon and Lung Cancer Research Panel v.2 (Thermo Fisher Scientific, Waltham, MA), the Oncomine Solid Tumor DNA kit (Thermo Fisher Scientific; Waltham, MA), or in-house developed NGS, mass spectrometry methods using the MassARRAY® Colon Panel (Sequenom, San Diego, CA) or the Myriapod® Colon kit (Diatech, Jesi, Italy), and Sanger sequencing using the ABI PRISM® SNaPshot® Multiplex Kit (Applied Biosystems, Foster City, CA) or in-house methods. Sequencing:Article Title: Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer. Article Snippet: M AN US CR IP T AC CE PT ED 13 Routine NRAS and BRAF mutation tests used as reference method The following routine reference methods were used to determine both the mutational status of NRAS and BRAF: NGS using the Ion Torrent AmpliSeqTM Colon and Lung Cancer Research Panel v.2 (Thermo Fisher Scientific, Waltham, MA), the Oncomine Solid Tumor DNA kit (Thermo Fisher Scientific; Waltham, MA), or in-house developed NGS, mass spectrometry methods using the MassARRAY® Colon Panel (Sequenom, San Diego, CA) or the Myriapod® Colon kit (Diatech, Jesi, Italy), and Sanger sequencing using the ABI PRISM® SNaPshot® Multiplex Kit (Applied Biosystems, Foster City, CA) or in-house methods. Multiplex Assay:Article Title: Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer. Article Snippet: M AN US CR IP T AC CE PT ED 13 Routine NRAS and BRAF mutation tests used as reference method The following routine reference methods were used to determine both the mutational status of NRAS and BRAF: NGS using the Ion Torrent AmpliSeqTM Colon and Lung Cancer Research Panel v.2 (Thermo Fisher Scientific, Waltham, MA), the Oncomine Solid Tumor DNA kit (Thermo Fisher Scientific; Waltham, MA), or in-house developed NGS, mass spectrometry methods using the MassARRAY® Colon Panel (Sequenom, San Diego, CA) or the Myriapod® Colon kit (Diatech, Jesi, Italy), and Sanger sequencing using the ABI PRISM® SNaPshot® Multiplex Kit (Applied Biosystems, Foster City, CA) or in-house methods. |